Immunohistochemically, the tumor cells in the prostate, skeletal muscle, and myocardium demonstrated strong cytoplasmic immunoreactivity for cytokeratin, but lacked the expression of uroplakin III, a marker specific for urothelial differentiation (Figure 4). This evidence concerns the gene UPK3A and neoplasm.